Written question asked by Dan Poulter (Conservative) on Wednesday, 17 October 2018, in the House of Commons. It was due for an answer on Monday, 22 October 2018. It was answered by Rishi Sunak (Conservative) on Thursday, 25 October 2018 on behalf of the Ministry of Housing, Communities and Local Government.
Buprenorphine
- Question
-
To ask the Secretary of State for Housing, Communities and Local Government, what discussions he has had with the Secretary of State for Health and Social Care on the financial effect on substance misuse services of the changes in the cost of prescribing buprenorphine.
- Answer
-
The Secretary of State has not met the Secretary of State for Health and Social Care to discuss the prescribing of buprenorphine. Funding to local authorities for public health is provided by the Department of Health and Social Care.
Secondary information
- Type
- Written question
- Reference
- 180691
- Session
- 2017-19
- Subjects
- Finance Misuse Prices Rehabilitation Departmental coordination Buprenorphine
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2018-10-29 21:05:27 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/180691
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/180691
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/180691